MedTrace Logo

Development of Methods for Enhance Human Milk Presentation During Storage and Warming

NCT02597088 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2015-11-04

No results posted yet for this study

Summary

Human milk (HM) is more than a food complex; in addition to micronutrients and human-coded bioactive complexes it also includes many antioxidants, antibacterial, prebiotics, probiotics, immune-boosting constituents, and many other bioactive components. Some of these components may deteriorate during storage, and expressed EHM starts deteriorating as soon as it leaves the breast. Nevertheless, whenever nursing at the breast or feeding of fresh EHM is not possible, feeding of stored EHM is considered the next best thing to feeding at the breast. Efficient heat transfer abilities affect both heating and cooling processes.

In this study the investigators wish to test a new device that permits rapid heating and cooling processes. The investigators plan to measure some thermolabile constituents of HM in order to determine whether they might be protected by a more gentle warming process. The investigators plan to collect milk from mother, to mix it and to test the effect of storage and heating.

This experiment is design to test the feasibility and the efficiency of the device.

Conditions

  • Human Milk, Breast Milk

Interventions

OTHER

Laboratory studies of the effect of human milk handling using a rage surface area bottle (study device)

Using laboratory studies of the effect of storage and heating on expressed human milk, the investigators will compare milk handled in regular bottle and bottle warmer and milk handled using the study device (large surface area bottle)

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    collaborator OTHER

  • Sharron Bransburg-Zabary Consulting services

    lead OTHER

Principal Investigators

  • Sharron Bransburg-Zabary, PhD · Consulting services

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-01-31
Completion
2016-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02597088 on ClinicalTrials.gov